SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. Bolotin S, Tran V, Osman S, Brown KA, et al. J Infect Dis 2021;223:1334-1338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bolotin S, Tran V, Osman S, Brown KA, et al. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. J Infect Dis 2021;223:1334-1338.
PMID: 33400794